VA
TMO icon

Valmark Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Valmark Advisers’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$507K Sell
1,010
-25
-2% -$12K 0.01% 498
2026
Q1 		$509K Sell
1,035
-44
-4% -$23.9K 0.01% 464
2025
Q4 		$625K Buy
1,079
+76
+8% +$43K 0.01% 408
2025
Q3 		$486K Buy
1,003
+80
+9% +$37.2K 0.01% 439
2025
Q2 		$374K Sell
923
-30
-3% -$12.5K 0.01% 496
2025
Q1 		$474K Sell
953
-117
-11% -$63.4K 0.01% 438
2024
Q4 		$557K Sell
1,070
-226
-17% -$124K 0.01% 397
2024
Q3 		$801K Buy
1,296
+179
+16% +$106K 0.01% 341
2024
Q2 		$617K Buy
1,117
+413
+59% +$237K 0.01% 360
2024
Q1 		$409K Buy
704
+105
+18% +$58.9K 0.01% 410
2023
Q4 		$318K Buy
599
+17
+3% +$8.23K 0.01% 413
2023
Q3 		$295K Sell
582
-8
-1% -$4.26K 0.01% 398
2023
Q2 		$308K Buy
590
+39
+7% +$21K 0.01% 397
2023
Q1 		$318K Buy
551
+30
+6% +$16.9K 0.01% 385
2022
Q4 		$287K Buy
521
+56
+12% +$29.7K 0.01% 378
2022
Q3 		$236K Buy
465
+15
+3% +$8.39K ﹤0.01% 378
2022
Q2 		$244K Sell
450
-25
-5% -$13.8K ﹤0.01% 375
2022
Q1 		$281K Buy
475
+24
+5% +$13.8K ﹤0.01% 376
2021
Q4 		$301K Sell
451
-32
-7% -$20K 0.01% 347
2021
Q3 		$276K Buy
+483
New +$265K 0.01% 338

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Valmark Advisers's TMO Position: Q2 2026 in Review

Valmark Advisers reduced its Thermo Fisher Scientific (TMO) stake by 2.4% in Q2 2026, selling an estimated $12K and leaving 1,010 shares worth $507K. The position accounts for 0.01% of the portfolio, ranked #498.

Valmark Advisers first reported a position in TMO in Q3 2021 and has held it in 20 quarters since. The position peaked at $801K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Valmark Advisers held 1,010 shares of Thermo Fisher Scientific worth $507K as of Q2 2026.
  • Valmark Advisers sold 25 Thermo Fisher Scientific shares in Q2 2026, an estimated $12K.
  • Thermo Fisher Scientific made up 0.01% of Valmark Advisers's portfolio in Q2 2026, its #498 holding.
  • Valmark Advisers first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 20 quarters since.
  • Valmark Advisers's Thermo Fisher Scientific position peaked at $801K in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Valmark Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.